Long-term results of treatment of chronic hepatitis B in an Iranian population.
Bafandeh
Yousef
Y
Saberi-Firoozi
Mehdi
M
Kamran
Bagheri Lankarani
BL
D000410:Alanine Transaminase / Q000187:drug effects; D000998:Antiviral Agents / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000187:drug effects; D004279:DNA, Viral / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006513:Hepatitis B e Antigens / Q000187:drug effects; D006515:Hepatitis B virus / Q000187:drug effects; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007492:Iran / Q000453:epidemiology; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D013997:Time Factors; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha; D019259:Lamivudine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase